오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - codeine phosphate hemihydrate,paracetamol -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - codeine phosphate hemihydrate, quantity: 9.6 mg; paracetamol, quantity: 499.9995 mg - tablet, uncoated - excipient ingredients: microcrystalline cellulose; magnesium stearate; quinoline yellow aluminium lake; povidone; croscarmellose sodium; pregelatinised maize starch; maize starch; stearic acid; crospovidone - for the temporary relief of acute moderate pain in patients over the age of 12 years.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - codeine phosphate hemihydrate,ibuprofen -

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - paracetamol; codeine phosphate hemihydrate - tablet - codeine and paracetamol

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; codeine phosphate hemihydrate; caffeine - capsule, hard - 500 mg/8 mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

chefaro ireland dac - paracetamol; codeine phosphate hemihydrate; caffeine - tablet - 500 mg/8 mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

미국 - 영어 - NLM (National Library of Medicine)

contract pharmacy services-pa - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia - have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated in patients with: - patients with significant respiratory depression [see warnings].  - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings].  - postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy [

미국 - 영어 - NLM (National Library of Medicine)

proficient rx lp - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] acetaminophen and codeine phosphate tablets are contraindicated in patients with: controlled substance acetaminophen and codeine phosphate tablet contains acetaminophen and codeine phosphate, a schedule cii controlled substance. abuse acetaminophen and codeine phosphate tablet contains  codeine, a substance with a high potential for abuse similar to other opioids including fentanyl, hydrocodone, hydrormorphone, methadone, morphine, oxycodone, oxymorphone, and tapentadol. acetaminophen and codeine phosphate tablets can be abused and is subject to

미국 - 영어 - NLM (National Library of Medicine)

ncs healthcare of ky, llc dba vangard labs - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain,where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see warnings ], reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options [e.g., non-opioid analgesics] - have not provided adequate analgesia, or are not expected to provide adequate analgesia - have not been tolerated, or are not expected to be tolerated acetaminophen and codeine phosphate tablets are contraindicated in patients with: - patients with significant respiratory depression [see warnings].  - patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings].  - postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy [see warnings]

미국 - 영어 - NLM (National Library of Medicine)

redpharm drug - acetaminophen (unii: 362o9itl9d) (acetaminophen - unii:362o9itl9d), codeine phosphate (unii: gsl05y1mn6) (codeine anhydrous - unii:ux6owy2v7j) - acetaminophen 300 mg - acetaminophen and codeine phosphate tablets are indicated for the management of mild to moderate pain where treatment with an opioid is appropriate and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses (see warnings), reserve acetaminophen and codeine phosphate tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics) have not provided adequate analgesia, or are not expected to provide adequate analgesia, have not been tolerated, or are not expected to be tolerated. acetaminophen and codeine phosphate tablets are contraindicated in: patients with significant respiratory depression (see warnings). patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment (see warnings). postoperative pain management in children who have undergone tonsillectomy and/or adenoidectomy (see warnings). patients with known or